Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Related Articles by Review for PubMed (Select 18829502)

1.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

2.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Wilken R, Veena MS, Wang MB, Srivatsan ES.

Mol Cancer. 2011 Feb 7;10:12. doi: 10.1186/1476-4598-10-12. Review.

3.

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.

PMID:
17405170
4.

Akt pathway as a target for therapeutic intervention in HNSCC.

Moral M, Paramio JM.

Histol Histopathol. 2008 Oct;23(10):1269-78. Review.

PMID:
18712679
5.

Antitumor, anti-invasion, and antimetastatic effects of curcumin.

Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R.

Adv Exp Med Biol. 2007;595:173-84. Review.

PMID:
17569210
6.

Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.

Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, Ferris RL, Lai SY.

Head Neck. 2007 Feb;29(2):163-88. Review.

PMID:
17312569
7.

Combination chemotherapy for head and neck cancer: the addition of Bcl-2 inhibitors.

Lo Russo L, Lo Muzio L.

Curr Opin Investig Drugs. 2009 Dec;10(12):1325-33. Review.

PMID:
19943204
8.
9.

NFkappaB-dependent chemoresistance in solid tumors.

Arlt A, Schäfer H.

Int J Clin Pharmacol Ther. 2002 Aug;40(8):336-47. Review.

PMID:
12467302
10.
11.

Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.

Vander Broek R, Snow GE, Chen Z, Van Waes C.

Oral Oncol. 2014 Oct;50(10):930-41. doi: 10.1016/j.oraloncology.2013.10.005. Epub 2013 Oct 28. Review.

PMID:
24177052
12.

Anti-cancer effects of curcumin on head and neck cancers.

Gao W, Chan JY, Wei WI, Wong TS.

Anticancer Agents Med Chem. 2012 Nov;12(9):1110-6. Review.

PMID:
22583425
13.

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.

Kunnumakkara AB, Anand P, Aggarwal BB.

Cancer Lett. 2008 Oct 8;269(2):199-225. doi: 10.1016/j.canlet.2008.03.009. Epub 2008 May 13. Review.

PMID:
18479807
14.

Curcumin and cancer: an "old-age" disease with an "age-old" solution.

Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB.

Cancer Lett. 2008 Aug 18;267(1):133-64. doi: 10.1016/j.canlet.2008.03.025. Epub 2008 May 6. Review.

PMID:
18462866
15.

MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.

Marioni G, Staffieri C, Staffieri A, De Filippis C, Blandamura S.

Acta Otolaryngol. 2009 May;129(5):476-80. doi: 10.1080/00016480802256079. Review.

PMID:
18615330
16.

Current overview of the role of Akt in cancer studies via applied immunohistochemistry.

Shtilbans V, Wu M, Burstein DE.

Ann Diagn Pathol. 2008 Apr;12(2):153-60. doi: 10.1016/j.anndiagpath.2007.12.001. Review.

PMID:
18325479
17.

Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma.

dos Santos LV, Carvalho AL.

Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):45-57. Review.

PMID:
21110823
18.

Curcumin as an inhibitor of angiogenesis.

Bhandarkar SS, Arbiser JL.

Adv Exp Med Biol. 2007;595:185-95. Review.

PMID:
17569211
19.

Multi-targeted therapy by curcumin: how spicy is it?

Goel A, Jhurani S, Aggarwal BB.

Mol Nutr Food Res. 2008 Sep;52(9):1010-30. doi: 10.1002/mnfr.200700354. Review.

PMID:
18384098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk